Suzhou Medsys Tech Co Ltd (603990) — Capital Reinvestment Ratio
Latest as of September 2025:
0.60x
Suzhou Medsys Tech Co Ltd (603990) has a Capital Reinvestment Ratio of 0.60x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥17.84 Million) in capital expenditures (CN¥10.62 Million). See 603990 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.60x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥17.84 Million
CNY
Capital Expenditures
CN¥10.62 Million
CNY
Data as of
Sep 2025
Most recent filing
Suzhou Medsys Tech Co Ltd Capital Reinvestment Ratio (2012–2022)
This chart tracks Suzhou Medsys Tech Co Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Suzhou Medsys Tech Co Ltd (2012–2022)
Year-by-year Capital Reinvestment Ratio for Suzhou Medsys Tech Co Ltd from 2012 to 2022. For live market cap and broader valuation context, see Suzhou Medsys Tech Co Ltd (603990) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.49x | CN¥50.51 Million | CN¥24.58 Million | ▼ -57.2% |
| 2021 | 1.14x | CN¥36.04 Million | CN¥40.99 Million | ▲ +1187.4% |
| 2020 | 0.09x | CN¥100.48 Million | CN¥8.88 Million | ▼ -84.9% |
| 2019 | 0.58x | CN¥22.04 Million | CN¥12.89 Million | ▲ +71.3% |
| 2018 | 0.34x | CN¥48.67 Million | CN¥16.62 Million | ▼ -60.3% |
| 2016 | 0.86x | CN¥32.56 Million | CN¥28.01 Million | ▼ -59.6% |
| 2015 | 2.13x | CN¥37.54 Million | CN¥79.94 Million | ▲ +38.9% |
| 2014 | 1.53x | CN¥40.82 Million | CN¥62.59 Million | ▲ +139.5% |
| 2013 | 0.64x | CN¥32.84 Million | CN¥21.03 Million | ▲ +193.0% |
| 2012 | 0.22x | CN¥10.83 Million | CN¥2.37 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow